FDA Inspection 1329942 — Munson Medical Center
The FDA completed an inspection of Munson Medical Center on Aug 7, 2026 in Traverse City, MI. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 4 citations were issued during this inspection. Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Aug 7, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Traverse City, MI (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 15045 | 21 CFR 610.47(b)(3) | Notify MD, Legal Rep, Relative of Trans Recipient[Consignee] |
| 155 | 21 CFR 606.160(b) | Required records |
| 160 | 21 CFR 606.160(a)(1) | Person performing, test results, interpretation |
| 76 | 21 CFR 606.100(b) | Establish, maintain and follow manufacturing SOPs |